<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2023-3-60-65</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-1432</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATIONS</subject></subj-group></article-categories><title-group><article-title>Клинические маски мраморной болезни</article-title><trans-title-group xml:lang="en"><trans-title>Clinical masks of marble disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3074-6156</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Радайкина</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Radaikina</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Радайкина Ольга Георгиевна,</p><p>430005, Саранск, ул. Большевистская, 68</p></bio><bio xml:lang="en"><p>Radaikina Olga Georgievna,</p><p>68, Bolshevistskaya Street, Saransk 430005</p></bio><email xlink:type="simple">mrsolga5@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2948-4865</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Усанова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Usanova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>430005, Саранск, ул. Большевистская, 68</p></bio><bio xml:lang="en"><p>68, Bolshevistskaya Street, Saransk 430005</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7082-6818</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фазлова</surname><given-names>И. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Fazlova</surname><given-names>I. Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>430005, Саранск, ул. Большевистская, 68</p></bio><bio xml:lang="en"><p>68, Bolshevistskaya Street, Saransk 430005</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9418-4538</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гуранова</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Guranova</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>430005, Саранск, ул. Большевистская, 68</p></bio><bio xml:lang="en"><p>68, Bolshevistskaya Street, Saransk 430005</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9645-8870</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Радайкина</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Radaikina</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>430005, Саранск, ул. Большевистская, 68</p></bio><bio xml:lang="en"><p>68, Bolshevistskaya Street, Saransk 430005</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.P. Ogarev Mordovia State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>10</day><month>07</month><year>2023</year></pub-date><volume>17</volume><issue>3</issue><fpage>60</fpage><lpage>65</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Радайкина О.Г., Усанова А.А., Фазлова И.Х., Гуранова Н.Н., Радайкина Е.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Радайкина О.Г., Усанова А.А., Фазлова И.Х., Гуранова Н.Н., Радайкина Е.В.</copyright-holder><copyright-holder xml:lang="en">Radaikina O.G., Usanova A.A., Fazlova I.K., Guranova N.N., Radaikina E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/1432">https://mrj.ima-press.net/mrj/article/view/1432</self-uri><abstract><p>Мраморная болезнь, или остеопетроз (ОПТ), редко встречается в практике ревматолога, терапевта или педиатра. В основе этой группы наследственных заболеваний лежит дефект образования, развития и функционирования остеокластов (ОКЛ), ведущий к нарушению процессов резорбции и ремоделирования костной ткани. Нарушение резорбции приводит к повышенной плотности и изменению качества костей, в результате чего они становятся более хрупкими. Как правило, заболевание манифестирует патологическими переломами. В последние десятилетия у 70% пациентов с ОПТ по крайней мере в 10 генах выявлены мутации, приводящие к нарушению функционирования ОКЛ. В зависимости от варианта наследования выделяют аутосомно-доминантный, аутосомно-рецессивный и промежуточный типы ОПТ. Аутосомно-доминантный ОПТ имеет доброкачественное течение, которое может быть как бессимптомным, так и характеризоваться множественными переломами костей и другими аномалиями позвоночника. Заболевание, как правило, манифестирует во взрослом или подростковом возрасте. Продолжительность жизни у больных этой группы не отличается от таковой в общей популяции. Злокачественный, или инфантильный, ОПТ связан с аутосомно-рецессивным вариантом наследования. Его клинические проявления наблюдаются с момента рождения, без лечения пациенты погибают в течение первого десятилетия жизни. У таких больных, кроме патологии скелета, отмечаются поражение кроветворной системы, сдавление черепно-мозговых нервов и нарушение их функции. Представлено клиническое наблюдение аутосомно-доминантного ОПТ, диагностированного во взрослом возрасте (38 лет), когда больной впервые обратился к врачу. Проведена дифференциальная диагностика с анкилозирующим спондилитом и паранеопластическим спондилоартритом.</p></abstract><trans-abstract xml:lang="en"><p>Marble disease, or osteopetrosis (OPT), is rare in the practice of a rheumatologist, internist or pediatrician. This group of hereditary diseases is based on a defect in the formation, development and functioning of osteoclasts (OCL), which leads to disruption of the processes of resorption and remodeling of bone tissue. Disturbance of resorption leads to increased density and changes in the quality of the bones, as a result of which they become more fragile. As a rule, the disease manifests with pathological fractures. In recent decades, 70% of patients with OPT have been found to have mutations in at least 10 genes that lead to impaired functioning of the OCL. Depending on the variant of inheritance, autosomal dominant, autosomal recessive and intermediate types of OPT are distinguished. Autosomal dominant OPT has a benign course that can be asymptomatic or characterized by multiple bone fractures and other spinal anomalies. The disease usually manifests in adulthood or adolescence. Life expectancy in patients of this group does not differ from that in the general population. Malignant, or infantile, OPT is associated with an autosomal recessive inheritance pattern. Its clinical manifestations are observed from the moment of birth, without treatment, patients die within the first decade of life. In such patients, in addition to the skeletal pathology, there is involvement of the hematopoietic system, compression of the cranial nerves and their function disturbance.</p><p>The article presents a clinical case of autosomal dominant OPT diagnosed in adulthood (at the age of 38), when the patient referred to the doctor for the first time. Differential diagnosis with ankylosing spondylitis and paraneoplastic spondyloarthritis was performed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>остеопетроз</kwd><kwd>остеокласты</kwd><kwd>аутосомно-доминантный остеопетроз</kwd><kwd>аутосомно-рецессивный остеопетроз</kwd><kwd>трансплантация гемопоэтических стволовых клеток</kwd></kwd-group><kwd-group xml:lang="en"><kwd>osteopetrosis</kwd><kwd>osteoclasts</kwd><kwd>autosomal dominant osteopetrosis</kwd><kwd>autosomal recessive osteopetrosis</kwd><kwd>transplantation of hematopoietic stem cells</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Bollerslev J, Andersen PE Jr. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone. 1988;9(1):7-13. doi: 10.1016/8756-3282(88)90021-x.</mixed-citation><mixed-citation xml:lang="en">Bollerslev J, Andersen PE Jr. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone. 1988;9(1):7-13. doi: 10.1016/8756-3282(88)90021-x.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Loria-Cortes R, Quesada-Calvo E, Cordero-Chaverri C. Osteopetrosis in children: a report of 26 cases. J Pediatr. 1977 Jul;91(1): 43-7. doi: 10.1016/s0022-3476(77)80441-1.</mixed-citation><mixed-citation xml:lang="en">Loria-Cortes R, Quesada-Calvo E, Cordero-Chaverri C. Osteopetrosis in children: a report of 26 cases. J Pediatr. 1977 Jul;91(1): 43-7. doi: 10.1016/s0022-3476(77)80441-1.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Старк З, Саварирайан Р. Остеопетроз. Нефрология. 2010;14(2):20-34.</mixed-citation><mixed-citation xml:lang="en">Stark Z, Savarirayan R. Osteopetrosis. Nefrologiya.2010;14(2):20-34. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кириллов АГ. Аутосомно-рецессивный ОПТ Чувашии. Автореф. дис. канд. мед. наук. Москва; 2005.</mixed-citation><mixed-citation xml:lang="en">Kirillov AG. Autosomal recessive OPT of Chuvashia. Autoref. diss. cand. med. sci. Moscow; 2005.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Кириллов АГ. Аутосомно-рецессивный ОПТ: ранняя диагностика. Российский педиатрический журнал. 2006;(4):47-51.</mixed-citation><mixed-citation xml:lang="en">Kirillov AG. Autosomal recessive OPT: early diagnosis. Rossiiskii pediatricheskii zhurnal. 2006;(4):47-51. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Калягин АН, Белозерцева ЛВ, Щаднева СИ и др. Остеопетроз («мраморная» болезнь). Современная ревматология. 2014; 8(1):23-6. doi: 10.14412/1996-7012-2014-1-23-26</mixed-citation><mixed-citation xml:lang="en">Kalyagin AN, Belozertseva LV, Shchadneva SI, et al. Osteopetrosis (marble bone disease). Sovremennaya revmatologiya = Modern Rheumatology Journal. 2014;8(1):23-6. (In Russ.). doi: 10.14412/1996-7012-2014-1-23-26</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009 Feb 20;4:5. doi: 10.1186/1750-1172-4-5.</mixed-citation><mixed-citation xml:lang="en">Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009 Feb 20;4:5. doi: 10.1186/1750-1172-4-5.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Penna S, Villa A, Capo V. Autosomal recessive osteopetrosis: mechanisms and treatments. Dis Model Mech. 2021 May 1;14(5): dmm048940. doi: 10.1242/dmm.048940. Epub 2021 May 10.</mixed-citation><mixed-citation xml:lang="en">Penna S, Villa A, Capo V. Autosomal recessive osteopetrosis: mechanisms and treatments. Dis Model Mech. 2021 May 1;14(5): dmm048940. doi: 10.1242/dmm.048940. Epub 2021 May 10.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Penna S, Capo V, Palagano E, et al. One disease, many genes: implications for the treatment of osteopetroses. Front Endocrinol (Lausanne). 2019 Feb 19;10:85. doi: 10.3389/fendo.2019.00085. eCollection 2019.</mixed-citation><mixed-citation xml:lang="en">Penna S, Capo V, Palagano E, et al. One disease, many genes: implications for the treatment of osteopetroses. Front Endocrinol (Lausanne). 2019 Feb 19;10:85. doi: 10.3389/fendo.2019.00085. eCollection 2019.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jacome-Galarza CE, Percin GI, Muller JT, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019 Apr;568(7753):541-5. doi: 10.1038/s41586-019-1105-7. Epub 2019 Apr 10.</mixed-citation><mixed-citation xml:lang="en">Jacome-Galarza CE, Percin GI, Muller JT, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019 Apr;568(7753):541-5. doi: 10.1038/s41586-019-1105-7. Epub 2019 Apr 10.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sobacchi C, Schulz A, Coxon FP, et al. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol. 2013 Sep;9(9):522-36. doi: 10.1038/nrendo.2013.137. Epub 2013 Jul 23.</mixed-citation><mixed-citation xml:lang="en">Sobacchi C, Schulz A, Coxon FP, et al. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol. 2013 Sep;9(9):522-36. doi: 10.1038/nrendo.2013.137. Epub 2013 Jul 23.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Palagano E, Menale C, Sobacchi C, et al. Genetics of osteopetrosis. Curr Osteoporos Rep. 2018 Feb;16(1):13-25. doi: 10.1007/s11914-018-0415-2.</mixed-citation><mixed-citation xml:lang="en">Palagano E, Menale C, Sobacchi C, et al. Genetics of osteopetrosis. Curr Osteoporos Rep. 2018 Feb;16(1):13-25. doi: 10.1007/s11914-018-0415-2.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Howaldt A, Nampoothiri S, Quell LM, et al. Sclerosing bone dysplasias with hallmarks of dysosteosclerosis in four patients carrying mutations in SLC29A3 and TCIRG1. Bone. 2019 Mar;120:495-503. doi: 10.1016/j.bone.2018.12.002. Epub 2018 Dec 8.</mixed-citation><mixed-citation xml:lang="en">Howaldt A, Nampoothiri S, Quell LM, et al. Sclerosing bone dysplasias with hallmarks of dysosteosclerosis in four patients carrying mutations in SLC29A3 and TCIRG1. Bone. 2019 Mar;120:495-503. doi: 10.1016/j.bone.2018.12.002. Epub 2018 Dec 8.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Howaldt A, Hennig AF, Rolvien T, et al. Adult osteosclerotic metaphyseal dysplasia with progressive osteonecrosis of the jaws and abnormal bone resorption pattern due to a LRRK1 splice site mutation. J Bone Miner Res. 2020 Jul;35(7):1322-32. doi: 10.1002/jbmr.3995. Epub 2020 Mar 19.</mixed-citation><mixed-citation xml:lang="en">Howaldt A, Hennig AF, Rolvien T, et al. Adult osteosclerotic metaphyseal dysplasia with progressive osteonecrosis of the jaws and abnormal bone resorption pattern due to a LRRK1 splice site mutation. J Bone Miner Res. 2020 Jul;35(7):1322-32. doi: 10.1002/jbmr.3995. Epub 2020 Mar 19.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly A, Younus A, Lekgwara P. Neurosurgical considerations in osteopetrosis. Interdisciplinary Neurosurgery. 2020;20. doi: 10.1016/j.inat.2020.100679.</mixed-citation><mixed-citation xml:lang="en">Kelly A, Younus A, Lekgwara P. Neurosurgical considerations in osteopetrosis. Interdisciplinary Neurosurgery. 2020;20. doi: 10.1016/j.inat.2020.100679.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Arruda M, Coelho MCA., Moraes AB, et al. Bone mineral density and microarchitecture in patients with autosomal dominant osteopetrosis: A report of two cases. J Bone Miner Res. 2016 Mar;31(3):657-62. doi: 10.1002/jbmr.2715. Epub 2015 Oct 20.</mixed-citation><mixed-citation xml:lang="en">Arruda M, Coelho MCA., Moraes AB, et al. Bone mineral density and microarchitecture in patients with autosomal dominant osteopetrosis: A report of two cases. J Bone Miner Res. 2016 Mar;31(3):657-62. doi: 10.1002/jbmr.2715. Epub 2015 Oct 20.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wu CC, Econs MJ, DiMeglio LA, et al. Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3111-23. doi: 10.1210/jc.2017-01127.</mixed-citation><mixed-citation xml:lang="en">Wu CC, Econs MJ, DiMeglio LA, et al. Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3111-23. doi: 10.1210/jc.2017-01127.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Di Zanni E, Palagano E, Lagostena E, et al. Pathobiologic mechanisms of neurodegeneration in osteopetrosis derived from structural and functional analysis of 14 ClC-7 mutants. J Bone Miner Res. 2021 Mar;36(3): 531-45. doi: 10.1002/jbmr.4200. Epub 2020 Nov 29.</mixed-citation><mixed-citation xml:lang="en">Di Zanni E, Palagano E, Lagostena E, et al. Pathobiologic mechanisms of neurodegeneration in osteopetrosis derived from structural and functional analysis of 14 ClC-7 mutants. J Bone Miner Res. 2021 Mar;36(3): 531-45. doi: 10.1002/jbmr.4200. Epub 2020 Nov 29.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Loke JY, Haslina MA, Kamalden TA. Osteopetrosis craniopathy: a rare cause of bilateral compressive optic neuropathy and facial nerve palsy. Postgrad Med J. 2019 Sep; 95(1127):513. doi: 10.1136/postgradmedj2019-136527. Epub 2019 Jul 10.</mixed-citation><mixed-citation xml:lang="en">Loke JY, Haslina MA, Kamalden TA. Osteopetrosis craniopathy: a rare cause of bilateral compressive optic neuropathy and facial nerve palsy. Postgrad Med J. 2019 Sep; 95(1127):513. doi: 10.1136/postgradmedj2019-136527. Epub 2019 Jul 10.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Capo V, Penna S, Merelli I, et al. Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis. Haematologica. 2021 Jan 1;106(1):74-86. doi: 10.3324/haematol.2019.238261.</mixed-citation><mixed-citation xml:lang="en">Capo V, Penna S, Merelli I, et al. Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis. Haematologica. 2021 Jan 1;106(1):74-86. doi: 10.3324/haematol.2019.238261.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Schulz AS, Moshous D, Steward CG, et al. Osteopetrosis. Consensus Guidelines for Diagnosis, Therapy and Follow-Up. 2015. https://Esid.Org/.2015.654.</mixed-citation><mixed-citation xml:lang="en">Schulz AS, Moshous D, Steward CG, et al. Osteopetrosis. Consensus Guidelines for Diagnosis, Therapy and Follow-Up. 2015. https://Esid.Org/.2015.654.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Coudert AE, De Vernejoul MC, Muraca M, et al. Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton. Int J Endocrinol. 2015;2015:372156. doi: 10.1155/2015/372156. Epub 2015 Mar 19.</mixed-citation><mixed-citation xml:lang="en">Coudert AE, De Vernejoul MC, Muraca M, et al. Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton. Int J Endocrinol. 2015;2015:372156. doi: 10.1155/2015/372156. Epub 2015 Mar 19.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Devi R, Siddaiahgari S, Lingappa L, et al. Case Report – Autosomal Recessive Infantile Malignant Osteopetrosis in India with novel mutation in TCIRG1 gene. European journal of human genetics. 2010;18:92.</mixed-citation><mixed-citation xml:lang="en">Devi R, Siddaiahgari S, Lingappa L, et al. Case Report – Autosomal Recessive Infantile Malignant Osteopetrosis in India with novel mutation in TCIRG1 gene. European journal of human genetics. 2010;18:92.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Orchard PJ, Fasth AL, Le Rademacher JL, et al. Hematopoietic stem cell transplantation for infantile osteopetrosis. Blood. 2015 Jul 9; 126(2):270-6. doi: 10.1182/blood-2015-01-625541. Epub 2015 May 26.</mixed-citation><mixed-citation xml:lang="en">Orchard PJ, Fasth AL, Le Rademacher JL, et al. Hematopoietic stem cell transplantation for infantile osteopetrosis. Blood. 2015 Jul 9; 126(2):270-6. doi: 10.1182/blood-2015-01-625541. Epub 2015 May 26.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrari G, Thrasher AJ, Aiuti A. Gene therapy using haematopoietic stem and progenitor cells. Nat Rev Genet. 2021 Apr;22(4): 216-34. doi: 10.1038/s41576-020-00298-5. Epub 2020 Dec 10.</mixed-citation><mixed-citation xml:lang="en">Ferrari G, Thrasher AJ, Aiuti A. Gene therapy using haematopoietic stem and progenitor cells. Nat Rev Genet. 2021 Apr;22(4): 216-34. doi: 10.1038/s41576-020-00298-5. Epub 2020 Dec 10.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhilyaev VM, Arapova SD, Mamedova EO, et al. Osteopetrosis: the follow-up of the disease in a patient who underwent hematopoietic stem cell transplantation at the age of 27 years. Osteoporosis and bone diseases. 2020; 23(1):14-9. doi: 10.14341/osteo12434</mixed-citation><mixed-citation xml:lang="en">Zhilyaev VM, Arapova SD, Mamedova EO, et al. Osteopetrosis: the follow-up of the disease in a patient who underwent hematopoietic stem cell transplantation at the age of 27 years. Osteoporosis and bone diseases. 2020; 23(1):14-9. doi: 10.14341/osteo12434</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Thrasher AJ, Williams DA. Evolving gene therapy in primary immunodeficiency. Mol Ther. 2017 May 3;25(5):1132-41. doi: 10.1016/ j.ymthe.2017.03.018. Epub 2017 Mar 31.</mixed-citation><mixed-citation xml:lang="en">Thrasher AJ, Williams DA. Evolving gene therapy in primary immunodeficiency. Mol Ther. 2017 May 3;25(5):1132-41. doi: 10.1016/ j.ymthe.2017.03.018. Epub 2017 Mar 31.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Löfvall H, Rothe M, Schambach A, et al. Hematopoietic stem cell-targeted neonatal gene therapy with a clinically applicable lentiviral vector corrects osteopetrosis in oc/oc mice. Hum Gene Ther. 2019 Nov;30(11): 1395-404. doi: 10.1089/hum.2019.047. Epub 2019 Jul 3.</mixed-citation><mixed-citation xml:lang="en">Löfvall H, Rothe M, Schambach A, et al. Hematopoietic stem cell-targeted neonatal gene therapy with a clinically applicable lentiviral vector corrects osteopetrosis in oc/oc mice. Hum Gene Ther. 2019 Nov;30(11): 1395-404. doi: 10.1089/hum.2019.047. Epub 2019 Jul 3.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Even-Or E, Stepensky P. How we approach malignant infantile osteopetrosis. Pediatr Blood Cancer. 2021 Mar;68(3):e28841. doi: 10.1002/pbc.28841. Epub 2020 Dec 12.</mixed-citation><mixed-citation xml:lang="en">Even-Or E, Stepensky P. How we approach malignant infantile osteopetrosis. Pediatr Blood Cancer. 2021 Mar;68(3):e28841. doi: 10.1002/pbc.28841. Epub 2020 Dec 12.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Stepensky P, Grisariu S, Avni B, et al. Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years. Blood Adv. 2019 Mar 26;3(6):862-8. doi: 10.1182/bloodadvances.2018025890.</mixed-citation><mixed-citation xml:lang="en">Stepensky P, Grisariu S, Avni B, et al. Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years. Blood Adv. 2019 Mar 26;3(6):862-8. doi: 10.1182/bloodadvances.2018025890.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Key LL Jr, Rodriguiz RM, Willi SM, et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med. 1995 Jun 15;332(24):1594-9. ssdoi: 10.1056/NEJM199506153322402.</mixed-citation><mixed-citation xml:lang="en">Key LL Jr, Rodriguiz RM, Willi SM, et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med. 1995 Jun 15;332(24):1594-9. ssdoi: 10.1056/NEJM199506153322402.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев НС, Борисова ЛВ, Дидиченко СН и др. ОПТ и эндопротезирование – клиническое наблюдение. Наука и инновации в медицине. 2017;2(4):65-72.</mixed-citation><mixed-citation xml:lang="en">Nikolaev NS, Borisova LV, Didichenko SN, et al. OPT and endoprosthetics – clinical observation. Nauka i innovatsii v meditsine. 2017;2(4):65-72. (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
